Literature DB >> 621281

Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

C C Schwartz, M Berman, Z R Vlahcevic, L G Halloran, D H Gregory, L Swell.   

Abstract

The present report has presented the first clear evidence in man for the existence of specific hepatic cholesterol precursor sites associated with the formation and secretion of bile acids and biliary cholesterol. These hepatic compartments derive virtually all their cholesterol from newly synthesized and lipoprotein free cholesterol. The model which is presented was formulated on current concepts of cholesterol metabolism in man and is concerned, at this initial stage, with the elucidation of the bile acid and biliary cholesterol compartments. The complexity of cholesterol metabolism in man necessitated an initial approach that would minimize the number of inputs of cholesterol into the system, allow for the sampling of several cholesterol compartments, and permit the simultaneous labeling of newly synthesized cholesterol and preformed cholesterol. To achieve these objectives, we studied the patient with a total bile fistula. Six patients were administered simultaneously pulse injections of labeled mevalonic acid and [(14)C]cholesterol. The qualitative features of the specific activity time course curves after labeled mevalonic acid revealed no precursor-product relationship between bile acid, biliary cholesterol, and plasma free cholesterol. The peak specific activity of the bile acids was reached in approximately 100 min and was higher than the biliary cholesterol, which was higher than the plasma free cholesterol. The plasma free cholesterol specific activity became higher than the other lipids after 12 h and remained higher throughout the period of study. Similar related observations were made with [(14)C]cholesterol. The data were then subjected to simulation analysis and modeling using the SAAM-27 computer program. Computer least-square fits of the data were obtained after the model was evolved. During the model development, the least number of compartments and transport pathways were introduced consistent with a good fit of the data. Of particular importance was the constraint that the model fit the data obtained from both [(14)C]cholesterol and labeled mevalonic acid. The same parameter values were used to fit the data from both tracers. The fluxes arrived at in the model indicate that 31% and 20%, respectively, of the cholesterol input into the bile acid and biliary cholesterol precursor sites were derived directly from the newly synthesized hepatic cholesterol. The remainder had its origin predominantly from lipoprotein free cholesterol. Plasma esterified cholesterol (as free) made a small contribution (11%) to the bile acid compartment. Similarly, 10% of the biliary cholesterol arose from an unknown hepatic site. The present report has provided the basis for a new procedure for studying in vivo cholesterol metabolism in man. Examination of the derived cholesterol flux rates between the compartments suggests the presence of an important mechanism regulating the partitioning of lipoprotein free cholesterol between the bile acid and biliary cholesterol precursor sites. Aberrations in the proportioning of precursor cholesterol between these sites could be a causative factor precipitating the excessive secretion of biliary cholesterol and the production of lithogenic bile.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621281      PMCID: PMC372552          DOI: 10.1172/JCI108952

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  The turnover of cholic acid in man: bile acids and steroids.

Authors:  S LINDSTEDT
Journal:  Acta Physiol Scand       Date:  1957-09-17

4.  The separation of complex lipide mixtures by the use of silicic acid chromatography.

Authors:  J HIRSCH; E H AHRENS
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

5.  The incorporation of radioactive acetate into biliary cholesterol and cholic acid.

Authors:  E STAPLE; S GURIN
Journal:  Biochim Biophys Acta       Date:  1954-11

6.  Kinetics and pool size of primary bile acids in man.

Authors:  Z R Vlahcevic; J R Miller; J T Farrar; L Swell
Journal:  Gastroenterology       Date:  1971-07       Impact factor: 22.682

7.  Studies on the cholesterol pool as the precursor of bile acids in the rat.

Authors:  M Ogura; J Shiga; K Yamasaki
Journal:  J Biochem       Date:  1971-12       Impact factor: 3.387

8.  Distribution and turnover of cholesterol in humans.

Authors:  P J Nestel; H M Whyte; D S Goodman
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

9.  Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods.

Authors:  S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1969-01       Impact factor: 5.922

10.  Turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  43 in total

Review 1.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

2.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

Authors:  YuZhen Zhang; Jaqueline R Da Silva; Muredach Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Quan Yuan; Genta Kakiyama; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2014-02-21       Impact factor: 5.922

4.  Biliary squalene levels in hepatobiliary disease.

Authors:  Y Nosaka; Y Yamanishi; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1985-08

5.  Central role of high density lipoprotein in plasma free cholesterol metabolism.

Authors:  C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

Authors:  T S Parker; D J McNamara; C Brown; O Garrigan; R Kolb; H Batwin; E H Ahrens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

Authors:  D J McNamara; E H Ahrens; T S Parker; K Morrissey
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  The effects of 3,5,5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile flow and biliary lipid secretion in the rat.

Authors:  G D Bell; R J Clegg; W R Ellis; B Middleton; D A White
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

9.  Plasma lipids and insulin in gall stone disease: a case-control study.

Authors:  R K Scragg; G D Calvert; J R Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01

10.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.